News

EMUC-Birtle-POUT

EMUC18: Updates on notable trials

Developments of notable trials were announced today during Plenary Session 06 New trials update: What we need to know which was chaired by Dr. Laurence Colette (BE), Dr. Ganesh Palapattu (US), Dr. Stephen Boorjian (US) and Dr. Alberto Bossi (FR). In his...
ESUI-De-Visschere

ESUI18: Prospects and impact of emerging imaging technologies

The rise of artificial intelligence, imaging-related toxicities, and other cutting-edge topics were featured during the session “Back to the future part I: What to expect in the next decade?”, which was moderated by  Prof. Dr. Jurgen Futterer  (NL), Prof....

EMUC18: Crucial MDT work in urological cancers

Multidisciplinary teams (MDTs) help achieve optimal management of urological malignancies, but more than putting MDTs in place, experts are in agreement that a lot more needs to be done to support and increase the contacts and links among various...

BCa18: Road maps in personalising bladder cancer treatment

Bladder cancer, one of the most aggressive recurrent onco-urological malignancies, poses a special challenge to cancer experts due to the lack of response from many patients particularly  those who are diagnosed at a late stage. The EAU Update on...

EMUC17: Using biomarkers in decision-making for RCC treatment

Renal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as biomarkers and other molecular techniques to distinguish aggressive diseases. With new research outcomes, physicians are hopeful that diagnosis and therapy...

EMUC16: National cancer prevention plans need a boost

National cancer plans, which are vital for an effective pan-European cancer care programme, should look closer at prevention, rehabilitation and survivorship issues, according to a public healthcare expert who spoke at the 8th European Multidisciplinary Meeting on Urological Cancers...

EMUC16: Re-thinking active surveillance strategies in PCa

With the emergence of more precise imaging and new results from genomic investigations, onco-urology experts are challenging standard medical strategies and are re-thinking their treatment regimens to achieve better patient care. At the concluding session of the 8th European...

EMUC16: Kidney cancer — from diagnosis to progression

Improving diagnosis and mapping out optimal treatment strategies for kidney cancer patients topped the second-day agenda of the 8th European Meeting on Urological Cancers (EMUC16) in Milan, Italy. The fourth plenary session focused on the challenges in kidney cancer...

EMUC16: Imaging and the treatment landscape for recurrent PCa

Current and prospective treatment strategies that employ image-guided approaches for prostate cancer recurrences were examined with experts exploring options in radiotherapy, surgery and chemotherapy. Speakers Steven Joniau (BE), Barbara Jereczek-Fossa (IT), George Thalmann (CH) and Cora Sternberg (IT) presented...